A. Puterman

Comparable long-term safety and efficacy of a novel budesonide/formoterol pressurized metered-dose inhaler versus budesonide/formoterol Turbuhaler in adolescents and adults with asthma.

A. Morice, A. Thorén, J. Ekelund, 2008, Pulmonary pharmacology & therapeutics.

Reduced interferon-gamma but normal IL-4 and IL-5 release by peripheral blood mononuclear cells from Xhosa children with atopic asthma.

P. Potter, E. Weinberg, M. Haus, 1997, The Journal of allergy and clinical immunology.

Asthma treatment in children: A pragmatic approach

H. Zar, M. Levin, P. de Waal, 2018, South African Medical Journal.

PBMCs from both atopic asthmatic and nonatopic children show a TH2 cytokine response to house dust mite allergen.

P. Potter, E. Weinberg, M. Haus, 2000, The Journal of allergy and clinical immunology.

Socioeconomic deprivation and asthma prevalence and severity in young adolescents

E. Bateman, S. Parnell, R. Ehrlich, 2002, European Respiratory Journal.

Socioeconomic status and prevalence of allergic rhinitis and atopic eczema symptoms in young adolescents

G. Joubert, R. Ehrlich, G. Joubert, 2004, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

Comparable safety of a novel budesonide/formoterol pMDI versus budesonide/formoterol turbuhaler® in adolescents and adults with asthma

A. Morice, O. Beckman, L. Arheden, 2005 .

Guidelines on the management of atopic dermatitis in South Africa

M. Levin, A. Manjra, R. Green, 2013 .